Phase 4 N=36 Pioglitazone and Serum Asymmetric Dimethylarginine (ADMA) in Patients With Diabetes
Diabetes
Primary: Asymmetric Dimethylarginine (ADMA) Level — .80; .75 umol/L — p=.37
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=1,421 ORCA - Oracea® for Rosacea: A Community-based Assessment
Rosacea
Primary: Change in Investigator's Global Assessment (IGA) Score From Baseline to Endpoint — 0; 0; 0; 0 participants
Phase 4 N=120 A Study in Korea of Entecavir Versus Lamivudine in Adults With Chronic Hepatitis B Infection
Chronic Hepatitis B
Primary: Percentage of Participants Who Achieved a Virologic Response at Week 24 — 92.86; 67.19 Percentage of participants — p=0.0006
Phase 4 N=100 AndroGel in Men With Major Depression and Incomplete Response to Antidepressant Treatment
Depressive Disorder, Major
Primary: 21-item Hamilton Depression Rating Scale Score (HAM-D) — 13.5; 15.6 units on a scale — p=0.71
Phase 4 N=442 Prospective, Multicentre, Open-label Study Evaluating 1.5 mg/Day of Fondaparinux.
Major Orthopaedic Surgery and Renal Impairment
Primary: Number of Patients With Major Bleedings Between Day 1 and Day 10. — 20 participants
Phase 4 N=17 Effectiveness of Levetiracetam in the Treatment of Body Dysmorphic Disorder
Body Dysmorphic Disorder
Primary: Number of Responders on the Yale-Brown Obsessive Compulsive Scale Modified for Body Dysmorphic Disorder (BDD-YBOCS) — 9 Participants
Phase 4 N=694 Olmesartan and an add-on Treatment in Patients With Mild to Moderate Hypertension
Essential Hypertension
Primary: The Percentage of Participants Treated to Target Blood Pressure Goals Overall and for Each Treatment Step From Baseline to Completion of Treatment During Which the Goal…
Phase 4 N=407 A Study to Determine the Effect of Sumatriptan and Naproxen Sodium Combination Tablet, Sumatriptan Tablet, and Naproxen Sodium Tablet on Blood Pressure When Treating Migraine Headaches That Occur During a 6-month Period
Migraine Disorders
Primary: Mean Change From Baseline in Systolic and Diastolic Blood Pressure at Month 6 for Sumatriptan/Naproxen — 111.7; 107.1; -2.9; 76.0 millimeters of mercury (mmHg)
Phase 4 N=72 Controlled Study of Humira in Subjects With Chronic Plaque Psoriasis of the Hands and/or Feet
Psoriasis
Primary: Number of Subjects With Physician's Global Assessment of Psoriasis (PGA) of Clear or Almost Clear at Week 16 — 1; 15 subjects — p=0.014
Phase 4 N=36 The Duration of the Suppressive Effects of Desloratadine on Allergen Prick Tests After Discontinuation (P04441)
Hypersensitivity
Primary: Duration of Suppressive Effect of Desloratadine After Discontinuation of a 1-week Treatment — 5; 4; NA Days
Phase 4 N=131 A Safety and Efficacy Study of Prograf in the Prevention of Erectile Dysfunction After Radical Prostatectomy
Erectile Dysfunction · Prostate Cancer
Primary: Erectile Function Domain Score Between Treated and Untreated Groups — 18.0; 23.5 Erectile Function Domain Score — p=0.111
Phase 4 N=20 Nicotine as an Adjuvant Analgesic for Third Molar Surgery
Dental Crowding
Primary: Pain Reported by Patient — 1.6; 2.9 score on a scale
Phase 4 N=68 Nicotine Patch as an Analgesic Adjuvant After Surgery
Pain
Primary: Postoperative Pain Score One Hour After Surgery — 5.78; 5.17; 4.32; 5.60 score on a scale
Phase 4 N=27 Topical Imiquimod Cream in Combination With Cryotherapy for the Treatment of Actinic Keratoses
Actinic Keratoses
Primary: Change From Baseline in Actinic Keratoses Count at 4-8 Weeks Post-treatment — -73.2; -62.0 Percent change
Phase 4 N=360 ADVANCE: Study to Evaluate Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease Receiving Hemodialysis
Chronic Kidney Disease · End Stage Renal Disease · Coronary Artery Calcification
Primary: Percent Change From Baseline in CAC Score — 43.74; 57.39 Units on a scale — p=0.073